---
title: "SDIC Capital: Net profit in the first half of 2025 increased by 35.96% year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255185998.md"
description: "SDIC Capital announced that in the first half of 2025, operating income was 6.785 billion yuan, a year-on-year increase of 1.02%; net profit was 1.7 billion yuan, a year-on-year increase of 35.96%. As of the end of the reporting period, total assets were 320.746 billion yuan, a year-on-year increase of 6.07%; net assets attributable to shareholders of the listed company were 55.784 billion yuan, a year-on-year increase of 1.57%"
datetime: "2025-08-29T11:09:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255185998.md)
  - [en](https://longbridge.com/en/news/255185998.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255185998.md)
---

# SDIC Capital: Net profit in the first half of 2025 increased by 35.96% year-on-year

SDIC Capital announced that in the first half of 2025, operating income was 6.785 billion yuan, a year-on-year increase of 1.02%; net profit was 1.7 billion yuan, a year-on-year increase of 35.96%. As of the end of the reporting period, total assets were 320.746 billion yuan, a year-on-year increase of 6.07%; net assets attributable to shareholders of the listed company were 55.784 billion yuan, a year-on-year increase of 1.57%

### Related Stocks

- [600061.CN](https://longbridge.com/en/quote/600061.CN.md)

## Related News & Research

- [Investeringsforeningen Nykredit Invest Balance suspender handel med udvalgte afdelinger](https://longbridge.com/en/news/286877547.md)
- [NYC Health and Hospitals says hackers stole medical data and fingerprints during breach affecting at least 1.8 million people](https://longbridge.com/en/news/286799449.md)
- [20:38 ETHyundai Bioscience Discloses XAFTY®'s IC50 Data for Ebola--"Secured Scientific Evidence for Immediate Treatment"](https://longbridge.com/en/news/287135394.md)
- [BioInvent to Host Virtual KOL Event to Discuss BI-1808 for the Treatment of Ovarian Cancer, on May 27, 2026](https://longbridge.com/en/news/287043048.md)
- [Apnimed's sleep apnea pill meets main goal in late-stage study](https://longbridge.com/en/news/286785038.md)